1. Home
  2. |Insights
  3. |Law360 Names Crowell & Moring’s Rebecca Baden Chaney to “Rising Stars” of Transportation List

Law360 Names Crowell & Moring’s Rebecca Baden Chaney to “Rising Stars” of Transportation List

Firm News | 2 min read | 07.13.21

Washington – July 13, 2021: Crowell & Moring LLP partner Rebecca Baden Chaney was one of three lawyers in the U.S. named to Law360’s 2021 list of “Rising Stars” in the transportation category. The award series recognizes lawyers under the age of 40 for their outstanding career accomplishments.  

Chaney serves as co-chair of Crowell & Moring’s Transportation Practice, which was named Law360’sTransportation Practice Group of the Year” in 2020. Law360 calls Chaney a “proven litigator and regulator advisor” in its feature profile about her work for clients in automotive, autonomous and electric vehicle, and micromobility product development.

Law360 cited Chaney’s extensive litigation experience, including a recent win for U.S.-based Dana Inc., a Tier 1 auto parts supplier, in a “high-stakes warranty and product defect dispute with German parts manufacturer Freudenberg Group.” Additionally, Law360 reported that Chaney was part of the Crowell & Moring team that successfully defended a major automotive manufacturer “in what was the first proposed nationwide class action against automakers over purportedly hackable cars.”

Chaney is now working with Crowell & Moring’s Transportation Practice co-chair Scott L. Winkelman to innovate how the firm serves clients that are leading the transportation revolution. “As transportation companies increasingly embrace emerging technology and the industry forges ahead in developing electric, self-driving or autonomous vehicles, or advanced mobility services, there will be plenty for practitioners like Chaney to grapple with as they help clients navigate the new landscape,” Law360 reported.

“These developing technologies, as well enhanced accessibility of all modes of transportation, are going to reshape this industry over the next 10 years,” Chaney told Law360. "One of the elements of my practice that I like is helping my clients to advance their businesses through legal strategies," she said.

The article also highlighted one of Chaney’s proudest moments as an attorney, in a pro bono case for an American mother who fought to keep her three children in the country in a dispute that crossed international borders.   

Chaney’s “Rising Star” profile can be viewed here, and the full list of transportation “Rising Stars” can be viewed here. The list of “Rising Stars” was selected by Law360 editors based on lawyers’ career accomplishments in their respective disciplines.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....